AMG National Trust Bank’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.7K Hold
10,000
﹤0.01% 476
2025
Q4
$35.6K Hold
10,000
﹤0.01% 452
2025
Q3
$34.9K Hold
10,000
﹤0.01% 452
2025
Q2
$20.5K Hold
10,000
﹤0.01% 446
2025
Q1
$11.4K Hold
10,000
﹤0.01% 441
2024
Q4
$3.09K Hold
10,000
﹤0.01% 447
2024
Q3
$3.27K Hold
10,000
﹤0.01% 440
2024
Q2
$4.6K Buy
+10,000
New +$8.54K ﹤0.01% 442

Other funds holding STLN

AMG National Trust Bank's STLN Position: Q1 2026 in Review

AMG National Trust Bank held its Starling Oncology Institute, Inc. Common Stock (STLN) position steady in Q1 2026 at 10,000 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #476.

AMG National Trust Bank first reported a position in STLN in Q2 2024 and has held it in 8 quarters since. The position peaked at $35.6K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • AMG National Trust Bank held 10,000 shares of Starling Oncology Institute, Inc. Common Stock worth $30.7K as of Q1 2026.
  • AMG National Trust Bank left its Starling Oncology Institute, Inc. Common Stock share count unchanged in Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of AMG National Trust Bank's portfolio in Q1 2026, its #476 holding.
  • AMG National Trust Bank first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2024 and has held it in 8 quarters since.
  • AMG National Trust Bank's Starling Oncology Institute, Inc. Common Stock position peaked at $35.6K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on AMG National Trust Bank's 13F filing for Q1 2026, filed 4 May 2026.